sec filing
AL
NASDAQ · ALT
Altimmune, Inc.
Healthcare · Biotechnology
$2.02
Down-$0.02 (-0.98%)
Updated Nov 3, 2026, 10:18 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 380.39M
- P/E ratio
- -4.59
- Dividend yield
- 0.00%
- 52-week range
- $1.99 – $4.04
- Volume
- 2.74M
- Avg. volume
- 4.9M
Price performance · ALT
ALT price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
ALT closed at $2.02 after 21 trading sessions, down 24.34% for the selected period.
- Last close
- $2.02
- Period change
- -24.34%
- Period low
- $2.02
- Period high
- $2.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $2.07 | $2.1063 | $2.01 | $2.02 | 2.74M |
| Oct 30, 2026 | $2.135 | $2.135 | $1.99 | $2.04 | 3.52M |
| Oct 29, 2026 | $2.105 | $2.18 | $2.10 | $2.14 | 2.68M |
| Oct 28, 2026 | $2.03 | $2.10 | $1.995 | $2.10 | 4.33M |
| Oct 27, 2026 | $2.07 | $2.15 | $2.01 | $2.04 | 4.97M |
| Oct 26, 2026 | $2.13 | $2.15 | $2.02 | $2.05 | 3.5M |
| Oct 23, 2026 | $2.16 | $2.20 | $2.06 | $2.12 | 2.6M |
| Oct 22, 2026 | $2.20 | $2.245 | $2.15 | $2.17 | 3.09M |
| Oct 21, 2026 | $2.31 | $2.35 | $2.19 | $2.23 | 4.5M |
| Oct 20, 2026 | $2.22 | $2.32 | $2.20 | $2.30 | 2.31M |
| Oct 19, 2026 | $2.22 | $2.26 | $2.18 | $2.23 | 2.61M |
| Oct 16, 2026 | $2.365 | $2.3691 | $2.17 | $2.20 | 4.24M |
| Oct 15, 2026 | $2.31 | $2.38 | $2.29 | $2.36 | 3.35M |
| Oct 14, 2026 | $2.40 | $2.41 | $2.29 | $2.31 | 5.63M |
| Oct 13, 2026 | $2.56 | $2.56 | $2.43 | $2.43 | 3.72M |
| Oct 12, 2026 | $2.59 | $2.625 | $2.56 | $2.56 | 2.16M |
| Oct 9, 2026 | $2.60 | $2.64 | $2.57 | $2.61 | 2.68M |
| Oct 8, 2026 | $2.66 | $2.66 | $2.55 | $2.60 | 4.93M |
| Oct 7, 2026 | $2.64 | $2.74 | $2.63 | $2.66 | 3.17M |
| Oct 6, 2026 | $2.70 | $2.70 | $2.64 | $2.67 | 7.63M |
| Oct 5, 2026 | $2.73 | $2.7467 | $2.65 | $2.67 | 3.84M |
Latest ALT news
The latest Smart Investors Daily articles mentioning ALT.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…